Affiliation:
1. Institute for Electrical Measurement Science and Fundamental Electrical Engineering and Laboratory for Emerging Nanometrology (LENA) Hans-Sommer-Str. 66 Braunschweig 38106 Germany
2. Leibniz Institute, German Collection of Microorganisms and Cell Cultures GmbH (DSMZ) Inhoffenstr. 7b Braunschweig 38124 Germany
Abstract
AbstractPolymerase chain reaction (PCR) requires thermal cycling and enzymatic reactions for sequence amplification, hampering their applications in point‐of‐care (POC) settings. Magnetic bioassays based on magnetic particle spectroscopy (MPS) and magnetic nanoparticles (MNPs) are isothermal, wash‐free, and can be quantitative. Realizing them amplification‐ and enzyme‐free on a benchtop device, they will become irreplaceable for POC applications. Here we demonstrate a first‐in‐class magnetic signal amplification circuit (MAC) that enables detection of whole genome of SARS‐CoV‐2 by combining the specificity of toehold‐mediated DNA strand displacement with the magnetic response of MNPs to declustering processes. Using MAC, we detect the N gene of SARS‐CoV‐2 samples at a concentration of 104 RNA copies/μl as determined by droplet digital PCR. Further, we demonstrate that MAC can reliably distinguish between SARS‐CoV‐2 and other human coronaviruses. Being a wash‐, amplification‐ and enzyme‐free biosensing concept and working at isothermal conditions (25 °C) on a low‐cost benchtop MPS device, our MAC biosensing concept offers several indispensable features for translating nucleic acid detection to POC applications.
Funder
Deutsche Forschungsgemeinschaft
Joachim Herz Stiftung
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献